Acceleron Pharma is a biopharmaceutical company developing drugs for important unmet medical needs through proprietary approaches that exploit the therapeutic potential of a large family of growth and differentiation factors.  Drug candidates will include both novel agonists and antagonists.  The company was founded in 2003 and builds upon important ongoing research in the laboratories of its academic founders and consultants.